Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
30
31
1
2
3
4
5
6
7
8
9
11
12
13
16
17
18
19
21
23
24
25
26
27
29
30
31
1
The International Meeting for Simulation in Healthcare
2015-01-10 - 2015-01-14    
All Day
Registration is Open! Please join us on January 10-14, 2015 for our fifteenth annual IMSH at the Ernest N. Morial Convention Center in New Orleans, Louisiana. Over [...]
Finding Time for HIPAA Amid Deafening Administrative Noise
2015-01-14    
1:00 pm - 3:00 pm
January 14, 2015, Web Conference 12pm CST | 1pm EST | 11am MT | 10am PST | 9am AKST | 8am HAST Main points covered: [...]
Meaningful Use  Attestation, Audits and Appeals - A Legal Perspective
2015-01-15    
2:00 pm - 3:30 pm
Join Jim Tate, HITECH Answers  and attorney Matt R. Fisher for our first webinar event in the New Year.   Target audience for this webinar: [...]
iHT2 Health IT Summit
2015-01-20 - 2015-01-21    
All Day
iHT2 [eye-h-tee-squared]: 1. an awe-inspiring summit featuring some of the world.s best and brightest. 2. great food for thought that will leave you begging for more. 3. [...]
Chronic Care Management: How to Get Paid
2015-01-22    
1:00 pm - 2:00 pm
Under a new chronic care management program authorized by CMS and taking effect in 2015, you can bill for care that you are probably already [...]
Proper Management of Medicare/Medicaid Overpayments to Limit Risk of False Claims
2015-01-28    
1:00 pm - 3:00 pm
January 28, 2015 Web Conference 12pm CST | 1pm EST | 11am MT | 10am PST | 9AM AKST | 8AM HAST Topics Covered: Identify [...]
Events on 2015-01-10
Events on 2015-01-20
iHT2 Health IT Summit
20 Jan 15
San Diego
Events on 2015-01-22
Latest News

Global Cancer Tumor Profiling Market Key Vendors, Drivers and Forecast 2024

According to the study, Cancer is proving the most fatal disease nowadays; therefor profiling cancer is in the great demand with seamlessly integrating next-generation sequencing (NGS) and in-situ hybridization for cancer profiling. In addition, cancer profiling for the detection of molecular & genetic level of cancers, and use of personalized and targeted approaches for treatment have propelled the market growth.

The Global Cancer Tumor Profiling Market  accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024.

The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The potential of cancer profiling is extended from common cancers such as lymphoma and breast cancer to molecular profiling of lung cancer, prostate cancer and acute leukemia.

No. of Report Pages: 350

Request for Free Sample of Global Cancer Tumor Profiling Market Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-tumor-profiling-market

Major Market Drivers and Restraints:

  • Technological advancements for identifying the cancer tumors.
  • Increasing the cancer incidences.
  • Increase in the use of biomarkers in tumor profiling.
  • Availability of Funding for Cancer Research
  • Increase in demand for next generation sequencing technique in cancer profiling.
  • Lack of Skilled Professionals and Infrastructure
  • Growth in demand of personalized medicines

Browse Full Detailed with TOC, Sample, Inquiry, Expert and Global Cancer Tumor Profiling Market Visit @ http://databridgemarketresearch.com/reports/global-cancer-tumor-profiling-market/

Market Segmentation by Types

By Technique the market is segmented in

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

By Application the market is segmented into

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research applications

On the basis of geography, global cancer tumor profiling market report covers data points for 28 countries across multiple geographies such as

  • North America & South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Top Key Players are:

tareIllumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc. , Caris Life Sciences, Helomics Corp., NanoString Technologies, Inc., Oxford Gene Technology, Abbott, BD, Hologic, Inc., Siemens Medical Solutions USA, Inc., Personal Genome Diagnostics, Inc., FOUNDATION MEDICINE, INC., Contextual Genomics, AGENDIA, Perthera, Inc., ApoCell, GenScript, Ribomed, Boreal Genomics Inc., Biotheranostics and Proteome Sciences among others.

For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cancer-tumor-profiling-market

Related Report  

Global Computed Tomography Devices Market – Industry Trends and Forecast to 2024

Global Computed Tomography Devices Market, By product (Low Slice CT Scanner, Medium Slice CT Scanner, High Slice CT Scanner), by Application (Cardiovascular, Oncology, Neurovascular, Abdomen and Pelvic, Pulmonary Angiogram, Spinal, Musculoskeletal), by End-User (Hospitals, Diagnostics Centers), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Access Report: http://databridgemarketresearch.com/reports/global-computed-tomography-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research